Medication-related Problems in CKD

被引:67
作者
Cardone, Katie E. [2 ]
Bacchus, Shaffeeulah [1 ]
Assimon, Magdalene M. [2 ]
Pai, Amy Barton [2 ]
Manley, Harold J. [1 ]
机构
[1] Village Hlth Dis Management, Dept Clin Pharm, Delmar, NY 12054 USA
[2] Albany Coll Pharm & Hlth Sci, Albany, NY USA
关键词
Medication-related problems; Chronic kidney disease; Pharmacist; Healthcare utilization; AMBULATORY HEMODIALYSIS-PATIENTS; CHRONIC RENAL-INSUFFICIENCY; CHRONIC KIDNEY-DISEASE; DRUG-RELATED PROBLEMS; PHARMACEUTICAL CARE; IMPACT; INTERVENTIONS; OPPORTUNITIES; PRESCRIPTION; PREVALENCE;
D O I
10.1053/j.ackd.2010.06.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with CKD are often prescribed heterogeneous medications to treat disease-associated comorbidities, to slow down progression of the disease, and to minimize morbidity and mortality rates. However, the medication regimens of this population are very complex, leading to an increased potential for medication-related problems (MRPs). As kidney function declines, the type and amount of medications a patient consumes increases, thereby putting them at a higher risk for MRPs. MRPs have been known to be associated with morbidity, mortality, and a lower quality of life. This review will summarize data on the prevalence and effect of MRPs, and strategies that can be used by clinicians to reduce and resolve MRPs. (C) 2010 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:404 / 412
页数:9
相关论文
共 49 条
[1]  
[Anonymous], CLIN NEPHROL
[2]   Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects [J].
Bailie, GR ;
Eisele, G ;
Liu, L ;
Roys, E ;
Kiser, M ;
Finkelstein, F ;
Wolfe, R ;
Port, F ;
Burrows-Hudson, S ;
Saran, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) :1110-1115
[3]   Hemodialysis morbidity and mortality: links to patient non-compliance [J].
Bander, STJ ;
Walters, BAJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (06) :649-653
[4]   An international study of patient compliance with hemodialysis [J].
Bleyer, AJ ;
Hylander, B ;
Sudo, H ;
Nomoto, Y ;
de la Torre, E ;
Chen, RA ;
Burkart, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (13) :1211-1213
[5]   Direct patient care services provided by a pharmacist on a multidisciplinary renal transplant team (vol 57, pg 1599, 2000) [J].
Chisholm, MA ;
Vollenweider, LJ ;
Mulloy, LL ;
Jagadeesan, M ;
Wade, WE ;
Dipiro, JT .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (21) :1994-1996
[6]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[7]  
Curtin R B, 1999, ANNA J, V26, P307
[8]  
Denhaerynd K, 2007, AM J CRIT CARE, V16, P222
[9]   Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans [J].
Doshi, Jalpa A. ;
Zhu, Jingsan ;
Lee, Bruce Y. ;
Kimmel, Stephen E. ;
Volpp, Kevin G. .
CIRCULATION, 2009, 119 (03) :390-U53
[10]  
Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192